Development of a Novel Polyleucine-Based Immunopotentiator for Subunit Vaccines Against Group A Streptococcus

Area of Science:

• Vaccinology
• Immunology
• Materials Science

Background:

• Mixture-based vaccine formulations simplify preparation and reduce costs.
• Novel adjuvant systems are needed to improve subunit vaccine efficacy.

Purpose of the Study:

• To design and characterize a novel polypeptide-based self-assembling nano adjuvant, L15K6.
• To evaluate the immunopotentiating capabilities of L15K6 in vitro and in vivo.

Main Methods:

• Design of L15K6: coupling of water-insoluble polyleucine (L15) with polylysine (K6).
• Assessment of L15K6 effects on dendritic cells: antigen uptake, maturation markers (CD40, CD80/86, MHC-II), and Toll-like receptor expression.
• RNA sequencing to analyze NF-κB pathway activation.
• Evaluation of L15K6 with Group A Streptococcus antigens and model antigens (ovalbumin, bovine serum albumin) in vivo.

Main Results:

• L15K6 demonstrated enhanced antigen uptake and dendritic cell maturation.
• L15K6 upregulated Toll-like receptor 4 and activated the NF-κB pathway.
• Co-delivery with antigens induced robust antigen-specific IgG responses and antibacterial activity.
• L15K6 outperformed alum adjuvant in eliciting high IgG levels against bovine serum albumin.

Conclusions:

• L15K6 is a simple, self-assembling polypeptide nano adjuvant with potent immunopotentiating properties.
• L15K6 enhances immune responses against various antigens, showing broad applicability.
• L15K6 holds significant promise for the development of next-generation subunit vaccines.